Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 17500
Corporate User License Price USD 750
Corporate User License Price INR 52500
Site License Price USD 500
Site License Price INR 35000
Request a Quote

Report Title

Caladrius Biosciences Inc (CLBS) - Medical Equipment - Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Caladrius Biosciences Inc (CLBS) - Medical Equipment - Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Caladrius Biosciences Inc (CLBS) - Medical Equipment - Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Caladrius Biosciences Inc (CLBS) - Medical Equipment - Deals and Alliances Profile



Executive Summary

Summary

Caladrius Biosciences Inc (Caladrius), formerly NeoStem Inc, is a clinical-stage biopharmaceutical company that develops cell therapy products. The company offers multiple technology platforms targeting cardiovascular indications and autoimmune diseases. The company's lead product CLBS03 is an autologous ex vivo polyclonal T regulatory cell clinical phase 2 therapy used in the treatment of type 1 diabetes mellitus. Its other product candidates include CLBS12 used in the treatment of critical limb ischemia; and CLBS14 used in the treatment of coronary microvascular dysfunction. The company offers T regulatory technology and CD34 technology. Caladrius serves biotechnology, pharmaceutical and medical product companies, and academic research institutions. The company operates in Basking Ridge, Irvine and New York, the US. Caladrius is headquartered in Basking Ridge, New Jersey, the US.

Caladrius Biosciences Inc (CLBS)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Caladrius Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Caladrius Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Caladrius Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Caladrius Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Caladrius Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Caladrius Biosciences Inc, Medical Equipment, Deal Details 10

Partnerships 10

Caladrius Biosciences Enters into Research Agreement with University of Southern California and California Institute of Technology 10

NeoStem Enters into Co-Development Agreement with Invetech 11

Equity Offering 12

Caladrius Biosciences Plans to Raise up to USD25 Million in Public Offering of Shares 12

Caladrius Biosciences Plans to Raise USD3.8 Million in Private Placement of Shares 13

NeoStem Raises USD29 Million in Public Offering of Shares 14

NeoStem to Raise USD30 Million in Private Placement of Shares 15

NeoStem Completes Public Offering Of Shares For USD 40.25 Million 16

NeoStem Files Registration Statement For Private Placement Of Shares For USD 8 Million 17

NeoStem Completes Public Offering Of Shares For USD 11.5 Million 18

NeoStem Completes Private Placement Of Common Stock For USD 3 Million 19

NeoStem Completes Public Offering Of Units For USD 6.8 Million 21

Asset Transactions 23

Hitachi Chemical Advanced Therapeutics Solutions Acquires Counter-Flow Centrifugation System from Caladrius Biosciences for USD2.5 Million 23

Acquisition 24

Hitachi Chemical Acquires Remaining 80.1% Interest in Progenitor Cell Therapy from Caladrius Biosciences 24

NeoStem Acquires California Stem Cell 25

Caladrius Biosciences Inc-Key Competitors 27

Caladrius Biosciences Inc-Key Employees 28

Caladrius Biosciences Inc-Locations And Subsidiaries 29

Head Office 29

Other Locations & Subsidiaries 29

Recent Developments 30

Financial Announcements 30

Aug 09, 2018: Caladrius Biosciences reports 2018 second quarter and first six months financial results 30

May 10, 2018: Caladrius Biosciences Reports 2018 First Quarter Financial Results 32

Mar 22, 2018: Caladrius Biosciences Reports 2017 Fourth Quarter and Year End Financial Results 33

Nov 09, 2017: Caladrius Biosciences Reports 2017 Third Quarter Results 35

Aug 10, 2017: Caladrius Biosciences Reports 2017 Second Quarter Results 37

May 15, 2017: Caladrius Biosciences Announces 2017 First Quarter Financial Results 39

Mar 17, 2017: Caladrius Biosciences Announces 2016 Fourth Quarter and Full Year Financial Results 41

Product News 43

Apr 09, 2018: Caladrius Biosciences to Participate at Upcoming April Conferences 43

May 01, 2017: Caladrius Biosciences to Participate at Upcoming May Conferences 44

Appendix 45

Methodology 45

About GlobalData 45

Contact Us 45

Disclaimer 45

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Caladrius Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Caladrius Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Caladrius Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Caladrius Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Caladrius Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Caladrius Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Caladrius Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Caladrius Biosciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

List of Tables

Caladrius Biosciences Inc, Medical Equipment, Key Facts, 2017 2

Caladrius Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Caladrius Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Caladrius Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Caladrius Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Caladrius Biosciences Inc, Deals By Market, 2012 to YTD 2018 8

Caladrius Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Caladrius Biosciences Enters into Research Agreement with University of Southern California and California Institute of Technology 10

NeoStem Enters into Co-Development Agreement with Invetech 11

Caladrius Biosciences Plans to Raise up to USD25 Million in Public Offering of Shares 12

Caladrius Biosciences Plans to Raise USD3.8 Million in Private Placement of Shares 13

NeoStem Raises USD29 Million in Public Offering of Shares 14

NeoStem to Raise USD30 Million in Private Placement of Shares 15

NeoStem Completes Public Offering Of Shares For USD 40.25 Million 16

NeoStem Files Registration Statement For Private Placement Of Shares For USD 8 Million 17

NeoStem Completes Public Offering Of Shares For USD 11.5 Million 18

NeoStem Completes Private Placement Of Common Stock For USD 3 Million 19

NeoStem Completes Public Offering Of Units For USD 6.8 Million 21

Hitachi Chemical Advanced Therapeutics Solutions Acquires Counter-Flow Centrifugation System from Caladrius Biosciences for USD2.5 Million 23

Hitachi Chemical Acquires Remaining 80.1% Interest in Progenitor Cell Therapy from Caladrius Biosciences 24

NeoStem Acquires California Stem Cell 25

Caladrius Biosciences Inc, Key Competitors 27

Caladrius Biosciences Inc, Key Employees 28

Caladrius Biosciences Inc, Other Locations 29

Caladrius Biosciences Inc, Subsidiaries 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Caladrius Biosciences Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person